| # | Drug | Count |
|---|---|---|
| 0 | ATEZOLIZUMAB | 11 |
| 1 | BEVACIZUMAB | 11 |
| 2 | REGORAFENIB | 4 |
| 3 | SORAFENIB | 4 |
| 4 | ACETAMINOPHEN | 3 |
| 5 | APIXABAN | 3 |
| 6 | FUROSEMIDE | 3 |
| 7 | LACTULOSE | 3 |
| 8 | RIFAXIMIN | 3 |
| 9 | SPIRONOLACTONE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CHLORINE DIOXIDE | 1 | 0.1111 |
| 1 | NITISINONE | 2 | 0.0021 |
| 2 | ORPHENADRINE CITRATE | 1 | 0.0016 |
| 3 | REGORAFENIB | 4 | 0.0003 |
| 4 | OXYTOCIN | 1 | 0.0003 |
| 5 | ATEZOLIZUMAB | 11 | 0.0003 |
| 6 | HYDROXYZINE PAMOATE | 1 | 0.0003 |
| 7 | GLUCAGON | 1 | 0.0002 |
| 8 | TREMELIMUMAB | 1 | 0.0002 |
| 9 | RADIUM RA 223 DICHLORIDE | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 2 | 0.0024 |
| 1 | Oxytocic [EPC] | 1 | 0.0003 |
| 2 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |
| 3 | Complement 5a Receptor Antagonist [EPC] | 1 | 0.0001 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 13 | 0.0001 |
| 5 | Bile Acid [EPC] | 2 | 0.0001 |
| 6 | Rifamycin Antibacterial [EPC] | 3 | 0.0001 |
| 7 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 11 | 0.0001 |
| 8 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 9 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |